6. Diagnostikk og utredning
6. 1. Hensikten med utredningen
6. 2. Presentasjonsformer
6. 3. Rekkefølge i utredningen
6. 4. Vurdering av pasienten
6. 5. Utbredelse av sykdommen – billeddiagnostikk
6. 6. Histopatologisk diagnose – prinsipper for prøvetaking
6. 7. Stadieinndeling
6. 8. Multidisiplinært team (MDT)-møte
6. 9. Histopatologisk diagnostikk
6. 10. Pulmonale noduli
6. 11. SLETTES Lungekreftscreening
6. 12. SLETTES Oversikt utredning av lungekreft i spesialisthelsetjenesten
6. 13. SLETTES Utfyllende informasjon om utredning av lungekreft
6. 14. SLETTES Laboratorietester
Aberle, D. R., Adams, A. M., Berg, C. D., Black, W. C., Clapp, J. D., Fagerstrom, R. M., Gareen, I. F., Gatsonis, C., ... National Lung Screening Trial Research Team (2011). Reduced lung-cancer mortality with low-dose computed tomographic screening. New England Journal of Medicine, 365(5), 395-409.
Aberle, D. R., DeMello, S., Berg, C. D., Black, W. C., Brewer, B., Church, T. R., Clingan, K. L., Duan, F., ... National Lung Screening Trial Research Team (2013). Results of the two incidence screenings in the National Lung Screening Trial. New England Journal of Medicine, 369(10), 920-31.
Aguilar, E., Gainor, J., Kravets, S., Khosrowjerdi, S., Lydon, C., Adeni, A., Subegdjo, S., Rizvi, H., ... Awad, M. (2018). Outcomes in NSCLC Patients Treated with First-Line Pembrolizumab and a PD-L1 TPS of 50-74% vs 75-100% or 0-89% vs 90-100%. Journal of Thoracic Oncology, 13(10), S367-S368.
Ali, M. S., Trick, W., Mba, B. I., Mohananey, D., Sethi, J., & Musani, A. I. (2017). Radial endobronchial ultrasound for the diagnosis of peripheral pulmonary lesions: A systematic review and meta-analysis. Respirology, 22(3), 443-453.
Al-Ibraheem, A., Hirmas, N., Fanti, S., Paez, D., Abuhijla, F., Al-Rimawi, D., Al-Rasheed, U., Abdeljalil, R., ... Mansour, A. (2021). Impact of (18)F-FDG PET/CT, CT and EBUS/TBNA on preoperative mediastinal nodal staging of NSCLC. BMC Medical Imaging, 21(1), 49.
Asamura, H., Chansky, K., Crowley, J., Goldstraw, P., Rusch, V. W., Vansteenkiste, J. F., Watanabe, H., Wu, Y. L., ... International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee, A. v. B. M. a. P. I. (2015). The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer. Journal of Thoracic Oncology, 10(12), 1675-84.
Asciak, R., Bedawi, E. O., Bhatnagar, R., Clive, A. O., Hassan, M., Lloyd, H., Reddy, R., Roberts, H., & Rahman, N. M. (2023). British Thoracic Society Clinical Statement on pleural procedures. Thorax, 78(Suppl 3), s43-s68.
Avasarala, S. K., Lentz, R. J., & Maldonado, F. (2021). Medical Thoracoscopy. Clinics in Chest Medicine, 42(4), 751-766.
Awad, M. M., Oxnard, G. R., Jackman, D. M., Savukoski, D. O., Hall, D., Shivdasani, P., Heng, J. C., Dahlberg, S. E., ... Sholl, L. M. (2016). MET Exon 14 Mutations in Non-Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression. Journal of Clinical Oncology,
Bankier, A. A., MacMahon, H., Goo, J. M., Rubin, G. D., Schaefer-Prokop, C. M., & Naidich, D. P. (2017). Recommendations for Measuring Pulmonary Nodules at CT: A Statement from the Fleischner Society. Radiology, 285(2), 584-600.
Baudin, E., Caplin, M., Garcia-Carbonero, R., Fazio, N., Ferolla, P., Filosso, P. L., Frilling, A., de Herder, W. W., ... ESMO Guidelines Committee (2021). Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 32(4), 439-451.
Bousema, J. E., Dijkgraaf, M. G. W., van der Heijden, E., Verhagen, A., Annema, J. T., van den Broek, F. J. C., & group, M. E. s. (2023). Endosonography With or Without Confirmatory Mediastinoscopy for Resectable Lung Cancer: A Randomized Clinical Trial. Journal of Clinical Oncology, 41(22), 3805-3815.
Brierley, J. D., Giuliani, M., O’Sullivan, B., Rous, B., Van Eycken, E. (2025). TNM Classification of Malignant Tumours. Wiley.
Brierley, J. D., Gospodarowicz, M. K., Wittekind, C. (2017). TNM Classification of Malignant Tumours. Wiley.
Callister, M. E., Baldwin, D. R., Akram, A. R., Barnard, S., Cane, P., Draffan, J., Franks, K., Gleeson, F., ... British Thoracic Society Standards of Care Committee (2015). British Thoracic Society guidelines for the investigation and management of pulmonary nodules. Thorax, 70 Suppl 2, ii1-ii54.
Caplin, M. E., Baudin, E., Ferolla, P., Filosso, P., Garcia-Yuste, M., Lim, E., Oberg, K., Pelosi, G., ... ENETS consensus conference participants (2015). Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids. Annals of Oncology,
Castello, A., Rossi, S., & Lopci, E. (2020). 18F-FDG PET/CT in Restaging and Evaluation of Response to Therapy in Lung Cancer: State of the Art. Current radiopharmaceuticals, 13(3), 228-237.
Chakrabarty, N., Mahajan, A., Patil, V., Noronha, V., & Prabhash, K. (2023). Imaging of brain metastasis in non-small-cell lung cancer: indications, protocols, diagnosis, post-therapy imaging, and implications regarding management. Clinical Radiology, 78(3), 175-186.
Chapel, D. B., Schulte, J. J., Husain, A. N., & Krausz, T. (2020). Application of immunohistochemistry in diagnosis and management of malignant mesothelioma. Translational lung cancer research, 9(Suppl 1), S3-S27.
Dam, G., Grønbæk, H., Sundlöv, A., Botling, J., Sundin, A., Petersen, R. H., Welin, S., Evensen, E. T., ... Langer, S. W. (2023). Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms. Acta Oncologica, 62(5), 431-437.
Damirov, F., Büsing, K., Yavuz, G., Hatz, R., Manapov, F., Michels, J., Hohenberger, P., & Roessner, E. (2023). Preoperative Hilar and Mediastinal Lymph Node Staging in Patients with Suspected or Diagnosed Lung Cancer: Accuracy of 18F-FDG-PET/CT:A Retrospective Cohort Study of 138 Patients. Diagnostics (Basel), 13(3)
Damirov, F., Stoleriu, M. G., Manapov, F., Büsing, K., Michels, J. D., Preissler, G., Hatz, R. A., Hohenberger, P., & Roessner, E. D. (2023). Histology of the Primary Tumor Correlates with False Positivity of Integrated 18F-FDG-PET/CT Lymph Node Staging in Resectable Lung Cancer Patients. Diagnostics (Basel), 13(11)
de Koning, H. J., van der Aalst, C. M., de Jong, P. A., Scholten, E. T., Nackaerts, K., Heuvelmans, M. A., Lammers, J. J., Weenink, C., ... Oudkerk, M. (2020). Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. New England Journal of Medicine, 382(6), 503-513.
De Leyn, P., Dooms, C., Kuzdzal, J., Lardinois, D., Passlick, B., Rami-Porta, R., Turna, A., Van Schil, P., ... Zielinski, M. (2014). Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer. European Journal of Cardio-Thoracic Surgery, 45(5), 787-98.
Detterbeck, F. C., Nicholson, A. G., Franklin, W. A., Marom, E. M., Travis, W. D., Girard, N., Arenberg, D. A., Bolejack, V., ... Participating Institutions (2016). The IASLC Lung Cancer Staging Project: Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification. Journal of Thoracic Oncology, 11(5), 639-650.
Dominioni, L., Rotolo, N., Mantovani, W., Poli, A., Pisani, S., Conti, V., Paolucci, M., Sessa, F., ... Imperatori, A. (2012). A population-based cohort study of chest x-ray screening in smokers: lung cancer detection findings and follow-up. BMC Cancer, 12, 18.
Dunne, E. G., Fick, C. N., & Jones, D. R. (2023). Mediastinal Staging in Non-Small-Cell Lung Cancer: Saying Goodbye to Mediastinoscopy. Journal of Clinical Oncology, 41(22), 3785-3790.
El-Sherief, A. H., Lau, C. T., Carter, B. W., & Wu, C. C. (2018). Staging Lung Cancer: Regional Lymph Node Classification. Radiologic Clinics of North America, 56(3), 399-409.
Folch, E. E., Labarca, G., Ospina-Delgado, D., Kheir, F., Majid, A., Khandhar, S. J., Mehta, H. J., Jantz, M. A., & Fernandez-Bussy, S. (2020). Sensitivity and Safety of Electromagnetic Navigation Bronchoscopy for Lung Cancer Diagnosis: Systematic Review and Meta-analysis. Chest, 158(4), 1753-1769.
George, J., Walter, V., Peifer, M., Alexandrov, L. B., Seidel, D., Leenders, F., Maas, L., Müller, C., ... Thomas, R. K. (2018). Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors. Nature communications, 9(1), 1048.
Gillespie, C. S., Mustafa, M. A., Richardson, G. E., Alam, A. M., Lee, K. S., Hughes, D. M., Escriu, C., & Zakaria, R. (2023). Genomic Alterations and the Incidence of Brain Metastases in Advanced and Metastatic NSCLC: A Systematic Review and Meta-Analysis. Journal of Thoracic Oncology, 18(12), 1703-1713.
Gould, M. K., Donington, J., Lynch, W. R., Mazzone, P. J., Midthun, D. E., Naidich, D. P., & Wiener, R. S. (2013). Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 143(5 Suppl), e93S-120S.
Grøndahl, V., Binderup, T., Langer, S. W., Petersen, R. H., Nielsen, K., Kjaer, A., Federspiel, B., & Knigge, U. (2019). Characteristics of 252 patients with bronchopulmonary neuroendocrine tumours treated at the Copenhagen NET Centre of Excellence. Lung Cancer, 132, 141-149.
Ha, D., Mazzone, P. J., Ries, A. L., Malhotra, A., & Fuster, M. (2016). The Utility of Exercise Testing in Patients with Lung Cancer. Journal of Thoracic Oncology, 11(9), 1397-410.
Hansell, D. M., Bankier, A. A., MacMahon, H., McLoud, T. C., Müller, N. L., & Remy, J. (2008). Fleischner Society: glossary of terms for thoracic imaging. Radiology, 246(3), 697-722.
Huo, Y. R., Chan, M. V., Habib, A. R., Lui, I., & Ridley, L. (2020). Pneumothorax rates in CT-Guided lung biopsies: a comprehensive systematic review and meta-analysis of risk factors. British Journal of Radiology, 93(1108), 20190866.
IARC (2021). Thoracic tumours (5 utg.) (WHO Classification of Tumours). Lyon: International Agency for Research on Cancer.
Johnson, P. T., Horton, K. M., & Fishman, E. K. (2009). Adrenal mass imaging with multidetector CT: pathologic conditions, pearls, and pitfalls. Radiographics, 29(5), 1333-51.
Kadota, K., Suzuki, K., Colovos, C., Sima, C. S., Rusch, V. W., Travis, W. D., & Adusumilli, P. S. (2012). A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma. Modern Pathology, 25(2), 260-71.
Kandathil, A., Kay, F. U., Butt, Y. M., Wachsmann, J. W., & Subramaniam, R. M. (2018). Role of FDG PET/CT in the Eighth Edition of TNM Staging of Non-Small Cell Lung Cancer. Radiographics, 38(7), 2134-2149.
Kandathil, A., & Subramaniam, R. M. (2022). FDG PET/CT for Primary Staging of Lung Cancer and Mesothelioma. Seminars in Nuclear Medicine, 52(6), 650-661.
Kauczor, H. U., Bonomo, L., Gaga, M., Nackaerts, K., Peled, N., Prokop, M., Remy-Jardin, M., von Stackelberg, O., ... European Respiratory Society (ERS) (2015). ESR/ERS white paper on lung cancer screening. European Respiratory Journal, 46(1), 28-39.
Kidane, B., Bott, M., Spicer, J., Backhus, L., Chaft, J., Chudgar, N., Colson, Y., D'Amico, T. A., ... Stiles, B. (2023). The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non-small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery, 166(3), 637-654.
Kim, M., Suh, C. H., Lee, S. M., Kim, H. C., Aizer, A. A., Yanagihara, T. K., Bai, H. X., Guenette, J. P., ... Kim, H. S. (2020). Diagnostic Yield of Staging Brain MRI in Patients with Newly Diagnosed Non-Small Cell Lung Cancer. Radiology, 297(2), 419-427.
Larici, A. R., Franchi, P., Del Ciello, A., Sica, G., Coviello, D., De Waure, C., Cicchetti, G., Rovere, G., ... Manfredi, R. (2021). Role of delayed phase contrast-enhanced CT in the intra-thoracic staging of non-small cell lung cancer (NSCLC): What does it add?. European Journal of Radiology, 144, 109983.
Lemaire, A., Nikolic, I., Petersen, T., Haney, J. C., Toloza, E. M., Harpole, D. H. ,. J., D'Amico, T. A., & Burfeind, W. R. (2006). Nine-year single center experience with cervical mediastinoscopy: complications and false negative rate. Annals of Thoracic Surgery, 82(4), 1185-9; discussion 1189-90.
Leong, T. L., Loveland, P. M., Gorelik, A., Irving, L., & Steinfort, D. P. (2019). Preoperative Staging by EBUS in cN0/N1 Lung Cancer: Systematic Review and Meta-Analysis. Journal of bronchology & interventional pulmonology, 26(3), 155-165.
Li, X., & Kong, L. (2023). Ultrasound versus computed tomography-guided transthoracic biopsy for pleural and peripheral lung lesions: a systematic review and meta-analysis. Acta Radiologica, 64(12), 2999-3008.
Li, Y., Chen, W., Xie, F., Huang, R., Liu, X., Xiao, Y., Cao, L., Hu, Y., ... Sun, J. (2023). Novel electromagnetic navigation bronchoscopy system for the diagnosis of peripheral pulmonary nodules: a prospective, multicentre study. Thorax, 78(12), 1197-1205.
Li, Y., Yang, F., Huang, Y. Y., & Cao, W. (2022). Comparison between computed tomography-guided core and fine needle lung biopsy: A meta-analysis. Medicine (Baltimore), 101(9), e29016.
Liao, X., Liu, M., Li, S., Huang, W., Guo, C., Liu, J., Xiong, Y., Zhang, J., ... Wang, R. (2023). The value on SUV-derived parameters assessed on (18)F-FDG PET/CT for predicting mediastinal lymph node metastasis in non-small cell lung cancer. BMC Medical Imaging, 23(1), 49.
Lim, E., Baldwin, D., Beckles, M., Duffy, J., Entwisle, J., Faivre-Finn, C., Kerr, K., Macfie, A., ... Society for Cardiothoracic Surgery in Great Britain and Ireland (2010). Guidelines on the radical management of patients with lung cancer. Thorax, 65 Suppl 3, iii1-27.
Lococo, F., Guerrera, F., Rena, O., Ampollini, L., Vannucci, J., Bertoglio, P., Ventura, L., Lyberis, P., ... Ruffini, E. (2022). Accuracy of (18)F-FDG in Detecting Stage I Lung Adenocarcinomas According to IASLC/ATS/ERS Classification. Heart, Lung & Circulation, 31(5), 726-732.
Lund-Iversen, M., Grøholt, K. K., Helland, Å., Borgen, E., & Brustugun, O. T. (2015). NUT expression in primary lung tumours. Diagnostic Pathology, 10, 156.
Lyon, A. R., López-Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J., Boriani, G., Cardinale, D., ... Group, E. S. D. (2022). 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). European Heart Journal, 43(41), 4229-4361.
MacMahon, H., Naidich, D. P., Goo, J. M., Lee, K. S., Leung, A. N. C., Mayo, J. R., Mehta, A. C., Ohno, Y., ... Bankier, A. A. (2017). Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017. Radiology, 284(1), 228-243.
Martinez-Zayas, G., Molina, S., & Ost, D. E. (2022). Sensitivity and complications of thoracentesis and thoracoscopy: a meta-analysis. European respiratory review, 31(166)
Marx, A., Chan, J. K. C., Chalabreysse, L., Dacic, S., Detterbeck, F., French, C. A., Hornick, J. L., Inagaki, H., ... Ströbel, P. (2022). The 2021 WHO Classification of Tumors of the Thymus and Mediastinum: What Is New in Thymic Epithelial, Germ Cell, and Mesenchymal Tumors?. Journal of Thoracic Oncology, 17(2), 200-213.
Massoth, L. R., Hung, Y. P., Dias-Santagata, D., Onozato, M., Shah, N., Severson, E., Duncan, D., Gillespie, B. J., ... Williams, E. A. (2020). Pan-Cancer Landscape Analysis Reveals Recurrent KMT2A- MAML2 Gene Fusion in Aggressive Histologic Subtypes of Thymoma. JCO precision oncology, 4
Matheos, T., Ram, L., & Canelli, R. (2020). Preoperative Evaluation for Thoracic Surgery. Thoracic Surgery Clinics, 30(3), 241-247.
Matsumoto, R., Takamori, S., Yokoyama, S., Hashiguchi, T., Murakami, D., Yoshiyama, K., Nishi, T., Kashihara, M., ... Akagi, Y. (2018). Lung function in the late postoperative phase and influencing factors in patients undergoing pulmonary lobectomy. Journal of Thoracic Disease, 10(5), 2916-2923.
Mynarek, G. K., & Bosse, G. (2016). Re: Behandling av gassembolier. Tidsskrift for den Norske Legeforening, 136(16), 1323-4.
Nakamura, K., Matsumoto, K., Inoue, C., Matsusue, E., & Fujii, S. (2021). Computed Tomography-guided Lung Biopsy: A Review of Techniques for Reducing the Incidence of Complications. Interventional radiology (Higashimatsuyama-shi (Japan), 6(3), 83-92.
Oken, M. M., Hocking, W. G., Kvale, P. A., Andriole, G. L., Buys, S. S., Church, T. R., Crawford, E. D., Fouad, M. N., ... PLCO Project Team (2011). Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA, 306(17), 1865-73.
Owens, C., Hindocha, S., Lee, R., Millard, T., & Sharma, B. (2023). The lung cancers: staging and response, CT, (18)F-FDG PET/CT, MRI, DWI: review and new perspectives. British Journal of Radiology, 96(1148), 20220339.
Özmen, Ö., ... Öztürk, A. (2021). Contribution of (18)F-FDG PET/CT in the Differential Diagnosis of Pulmonary Hamartomas and Pulmonary Carcinoids. Molecular imaging and radionuclide therapy, 30(2), 101-106.
Padda, S. K., Riess, J. W., Schwartz, E. J., Tian, L., Kohrt, H. E., Neal, J. W., West, R. B., & Wakelee, H. A. (2015). Diffuse high intensity PD-L1 staining in thymic epithelial tumors. Journal of Thoracic Oncology, 10(3), 500-8.
Pedersen, J. H., Sørensen, J. B., Saghir, Z., Fløtten, Ø., Brustugun, O. T., Ashraf, H., Strand, T. E., Friesland, S., ... Gudbjartsson, T. (2017). Implementation of lung cancer CT screening in the Nordic countries. Acta Oncologica, 56(10), 1249-1257.
Pencharz, D., Modi, S., Bandyopadhyay, S., Alhun, U., Marchbank, N., Patel, A., & Wagner, T. (2022). Absence of clinical benefit of FDG PET-CT in staging T1 part-solid lung adenocarcinoma. Clinical Radiology, 77(3), 195-202.
Postmus, P. E., Kerr, K. M., Oudkerk, M., Senan, S., Waller, D. A., Vansteenkiste, J., Escriu, C., Peters, S., & ESMO Guidelines Committee (2017). Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 28(suppl_4), iv1-iv21.
Prosperi, D., Carideo, L., Russo, V. M., Meucci, R., Campagna, G., Lastoria, S., & Signore, A. (2023). A Systematic Review on Combined [(18)F]FDG and (68)Ga-SSA PET/CT in Pulmonary Carcinoid. Journal of Clinical Medicine Research, 12(11)
Radovich, M., Pickering, C. R., Felau, I., Ha, G., Zhang, H., Jo, H., Hoadley, K. A., Anur, P., ... Cancer Genome Atlas Network (2018). The Integrated Genomic Landscape of Thymic Epithelial Tumors. Cancer Cell, 33(2), 244-258.e10.
Rami-Porta, R., Nishimura, K. K., Giroux, D. J., Detterbeck, F., Cardillo, G., Edwards, J. G., Fong, K. M., Giuliani, M., ... Members of the IASLC Staging and Prognostic Factors Committee and of the Advisory Boards, a. P. I. (2024). The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groups in the Forthcoming (Ninth) Edition of the TNM Classification for Lung Cancer. Journal of Thoracic Oncology, 19(7), 1007-1027.
Rekhtman, N. (2010). Neuroendocrine tumors of the lung: an update. Archives of Pathology and Laboratory Medicine, 134(11), 1628-38.
Rekhtman, N., Desmeules, P., Litvak, A. M., Pietanza, M. C., Santos-Zabala, M. L., Ni, A., Montecalvo, J., Chang, J. C., ... Lai, W. C. (2019). Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices. Modern Pathology, 32(8), 1106-1122.
Rivera, M. P., Mehta, A. C., & Wahidi, M. M. (2013). Establishing the Diagnosis of Lung Cancer: Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 143(5 Suppl), e142S-65S.
Rogasch, J. M. M., Frost, N., Bluemel, S., Michaels, L., Penzkofer, T., von Laffert, M., Temmesfeld-Wollbrück, B., Neudecker, J., ... Furth, C. (2021). FDG-PET/CT for pretherapeutic lymph node staging in non-small cell lung cancer: A tailored approach to the ESTS/ESMO guideline workflow. Lung Cancer, 157, 66-74.
Rogasch, J. M. M., Hofheinz, F., van Heek, L., Voltin, C. A., Boellaard, R., & Kobe, C. (2022). Influences on PET Quantification and Interpretation. Diagnostics (Basel), 12(2)
Saghir, Z., Dirksen, A., Ashraf, H., Bach, K. S., Brodersen, J., Clementsen, P. F., Døssing, M., Hansen, H., ... Pedersen, J. H. (2012). CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax, 67(4), 296-301.
Salati, M., & Brunelli, A. (2016). Risk Stratification in Lung Resection. Current surgery reports, 4(11), 37.
Schneider, J. (2006). Tumor markers in detection of lung cancer. Advances in Clinical Chemistry, 42, 1-41.
Schoenmaekers, J. J. A. O., Dingemans, A. C., & Hendriks, L. E. L. (2018). Brain imaging in early stage non-small cell lung cancer: still a controversial topic?. Journal of Thoracic Disease, 10(Suppl 18), S2168-S2171.
Schreuder, A., Jacobs, C., Scholten, E. T., van Ginneken, B., Schaefer-Prokop, C. M., & Prokop, M. (2020). Typical CT Features of Intrapulmonary Lymph Nodes: A Review. Radiol Cardiothorac Imaging, 2(4), e190159.
Schwartz, L. H., Gandras, E. J., Colangelo, S. M., Ercolani, M. C., & Panicek, D. M. (1999). Prevalence and importance of small hepatic lesions found at CT in patients with cancer. Radiology, 210(1), 71-4.
Seol, H. Y., Kim, Y. S., & Kim, S. J. (2021). Predictive Value of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for Assessment of Occult Lymph Node Metastasis in Non-Small Cell Lung Cancer. Oncology, 99(2), 96-104.
Silvestri, G. A., Gonzalez, A. V., Jantz, M. A., Margolis, M. L., Gould, M. K., Tanoue, L. T., Harris, L. J., & Detterbeck, F. C. (2013). Methods for Staging Non-small Cell Lung Cancer: Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 143(5 Suppl), e211S-50S.
Skov, B. G., & Skov, T. (2017). Paired Comparison of PD-L1 Expression on Cytologic and Histologic Specimens From Malignancies in the Lung Assessed With PD-L1 IHC 28-8pharmDx and PD-L1 IHC 22C3pharmDx. Applied Immunohistochemistry & Molecular Morphology, 25(7), 453-459.
Smilowitz, N. R., & Berger, J. S. (2020). Perioperative Cardiovascular Risk Assessment and Management for Noncardiac Surgery: A Review. JAMA, 324(3), 279-290.
Spiro, S. G. (2012). Screening for lung cancer: we still need to know more. Thorax, 67(4), 283-5.
Stevens, T. M., Morlote, D., Xiu, J., Swensen, J., Brandwein-Weber, M., Miettinen, M. M., Gatalica, Z., & Bridge, J. A. (2019). NUTM1-rearranged neoplasia: a multi-institution experience yields novel fusion partners and expands the histologic spectrum. Modern Pathology, 32(6), 764-773.
Stovold, R., Blackhall, F., Meredith, S., Hou, J., Dive, C., & White, A. (2012). Biomarkers for small cell lung cancer: neuroendocrine, epithelial and circulating tumour cells. Lung Cancer, 76(3), 263-8.
Suárez-Piñera, M., Belda-Sanchis, J., Taus, A., Sánchez-Font, A., Mestre-Fusco, A., Jiménez, M., & Pijuan, L. (2018). FDG PET-CT SUVmax and IASLC/ATS/ERS histologic classification: a new profile of lung adenocarcinoma with prognostic value. American Journal of Nuclear Medicine and Molecular Imaging, 8(2), 100-109.
Suh, Y. J., Park, C. M., Han, K., Jeon, S. K., Kim, H., Hwang, E. J., Lee, J. H., Paeng, J. C., ... Goo, J. M. (2020). Utility of FDG PET/CT for Preoperative Staging of Non-Small Cell Lung Cancers Manifesting as Subsolid Nodules With a Solid Portion of 3 cm or Smaller. AJR. American journal of roentgenology, 214(3), 514-523.
Tomiyama, N., Yasuhara, Y., Nakajima, Y., Adachi, S., Arai, Y., Kusumoto, M., Eguchi, K., Kuriyama, K., ... Yamada, K. (2006). CT-guided needle biopsy of lung lesions: a survey of severe complication based on 9783 biopsies in Japan. European Journal of Radiology, 59(1), 60-4.
Travis, W. D., Brambilla, E., Rami-Porta, R., Vallières, E., Tsuboi, M., Rusch, V., Goldstraw, P., & International Staging Committee (2008). Visceral pleural invasion: pathologic criteria and use of elastic stains: proposal for the 7th edition of the TNM classification for lung cancer. Journal of Thoracic Oncology, 3(12), 1384-90.
Upadhya, P., Ananthraju, A., Vadala, R., & Mohanty Mohapatra, M. (2021). Endocrine paraneoplastic syndromes in lung cancer: a respiratory physician's perspective. Advances in respiratory medicine, 89(4), 403-412.
Veronesi, G., Maisonneuve, P., Bellomi, M., Rampinelli, C., Durli, I., Bertolotti, R., & Spaggiari, L. (2012). Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study. Annals of Internal Medicine, 157(11), 776-84.
Vilmann, P., Clementsen, P. F., Colella, S., Siemsen, M., De Leyn, P., Dumonceau, J. M., Herth, F. J., Larghi, A., ... Annema, J. T. (2015). Combined endobronchial and oesophageal endosonography for the diagnosis and staging of lung cancer. European Society of Gastrointestinal Endoscopy (ESGE) Guideline, in cooperation with the European Respiratory Society (ERS) and the European Society of Thoracic Surgeons (ESTS). European Respiratory Journal, 46(1), 40-60.
Weir-McCall, J. R., Harris, S., Miles, K. A., Qureshi, N. R., Rintoul, R. C., Dizdarevic, S., Pike, L., Cheow, H. K., & Gilbert, F. J. (2021). Impact of solitary pulmonary nodule size on qualitative and quantitative assessment using 18F-fluorodeoxyglucose PET/CT: the SPUTNIK trial. European Journal of Nuclear Medicine and Molecular Imaging, 48(5), 1560-1569.
White, C. S., & Rubin, G. D. (2020). The Puzzle of the Perifissural Nodule. Radiol Cardiothorac Imaging, 2(4), e200409.
Wilson, J. M., & Jungner, Y. G. (1968). [Principles and practice of mass screening for disease]. Boletín de la Oficina Sanitaria Panamericana, 65(4), 281-393.
Wu, D., Liu, Y. Y., Wang, T., Huang, Y. Y., & Xia, P. (2023). Computed tomography-guided lung biopsy with rapid on-site evaluation for diagnosis of lung lesions: a meta-analysis. Journal of Cardiothoracic Surgery, 18(1), 122.
Yang, B., Lee, H., Um, S. W., Kim, K., Zo, J. I., Shim, Y. M., Jung Kwon, O., Lee, K. S., ... Kim, H. (2019). Incidence of brain metastasis in lung adenocarcinoma at initial diagnosis on the basis of stage and genetic alterations. Lung Cancer, 129, 28-34.
Yokoba, M., Ichikawa, T., Harada, S., Naito, M., Sato, Y., & Katagiri, M. (2018). Postoperative pulmonary function changes according to the resected lobe: a 1-year follow-up study of lobectomized patients. Journal of Thoracic Disease, 10(12), 6891-6902.
Siste faglige endring: 26. mai 2026